Cognitive impairment in Duchenne muscular dystrophy

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Duchenne muscular dystrophy (DMD) is a genetic disorder primarily affecting muscles.
• Cognitive deficits are frequently observed in DMD patients, but their underlying mechanisms are not fully understood.
• Dystrophin gene mutations are the hallmark of DMD.

Purpose of the Study:

• To investigate cognitive function in DMD patients.
• To explore the relationship between dystrophin gene mutations and cognitive performance.
• To identify potential neurobiological correlates of cognitive impairment in DMD.

Main Methods:

• Cognitive assessments including Wechsler scales and Raven IQ tests were administered to 50 DMD patients.
• Dystrophin gene deletions were analyzed.
• (18F)-fluorodeoxyglucose positron emission tomography (FDG-PET) was used to assess brain metabolism.

Main Results:

• 31% of DMD patients had a full intelligence quotient (FIQ) below 75, indicating intellectual disability.
• Verbal IQ was more affected than performance IQ in younger patients.
• Cerebellar hypometabolism was observed in all examined DMD patients, with variable involvement of cortical areas.
• No significant correlation was found between genetic data and psychometric assessment outcomes.
• Low performance IQ correlated with macroglossia.

Conclusions:

• Cognitive impairment in DMD is associated with cerebral and cerebellar hypometabolism.
• Neuropsychological deficits in DMD patients are consistent, irrespective of intellectual disability.
• The study suggests a role for altered brain metabolism in the cognitive profile of DMD.